LIPOFOR Film-coated tablet Ref.[28221] Active ingredients: Gemfibrozil

Source: Υπουργείο Υγείας (CY)  Revision Year: 2018  Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus

Product name and form

Lipofor 600 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

White, oval, film-coated tablets.

Qualitative and quantitative composition

Each tablet contains 600 mg gemfibrozil.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Gemfibrozil

Gemfibrozil is a lipid regulating agent which regulates lipid fractions. Gemfibrozil stimulates the peripheral lipolysis of triglyceride rich lipoproteins such as VLDL and cholymicrons by stimulation of LPL. Gemfibrozil also inhibits synthesis of VLDL in the liver.
List of Excipients

Core:

Hydroxypropylcellulose
Cellulose, microcrystalline
Starch, pregelatinised
Polysorbate 80
Sodium starch glycolate (type A)
Silica, colloidal anhydrous
Magnesium stearate

Coating:

Hypromellose
Macrogol 400
Titanium dioxide
Talc

Pack sizes and marketing

PVC/Aluminium blisters. Pack-sizes of 30 and 100 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus

Marketing authorization dates and numbers

14716

Date of first authorization: 19 April 1994
Date of latest renewal: 30 September 2011

Drugs

Drug Countries
LIPOFOR Cyprus, Hong Kong, Singapore
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈